Feedback

RSS Feed

Group Chairs
- Jeffry M. Nichols
  Chair
- William R. Boudreaux
  Chair

Featured CLEar Knowledge
Now Program
- Patent Reform: What Should You Be Doing Now? Part II
- Allen R. Baum and Ryan L. Marshall discussed strategies for taking advantage of the new proceedings and provisions in the U.S. patent system. Brinks is an accredited MCLE provider in Illinois and this program is worth 1.0 hour of general CLE credit.
- Click on the video below to see a brief preview of this program.

Loading the player ...

Biotechnology & Pharmaceutical

Life-improving innovations in biotechnology and pharmaceuticals require intellectual property counsel with unique technical and legal expertise to protect the assets upon which companies are established and flourish. The BioPharma Group at Brinks Hofer Gilson & Lione includes attorneys and patent agents who counsel a diverse array of clients — from start-ups to prestigious academic institutions to global corporations — on the ever-evolving laws concerning intellectual property in the United States and worldwide.

The BioPharma Group has key experience and success with biopharma litigation, including Hatch-Waxman cases, USPTO proceedings, biopharma patent drafting and prosecution, and licensing and evaluation of biopharma intellectual property. Our BioPharma Group members hold wide-ranging science and engineering degrees, many at the advanced level, and have extensive industry work experience or education in scientific disciplines, including chemistry, pharmacology, immunoassay test development, small molecule organic chemistry, cell biology and genetics.